Compare lab measurements, vendor test histories and original reports for Liraglutide.
What the Liraglutide record shows
Evidence through 2026-09-08
TitrateLab tracks 8 published Liraglutide certificate-of-analysis source records through 2026-09-08, each with a recorded purity or measured-versus-label amount result. Across 8 records with a numeric peptide-purity result, including zero, the median reported purity is 99.6%. Across 4 records with measured-versus-label dose data, 100% are within 10% of the labeled quantity. This is a public convenience sample, not a randomized market survey; one result describes one submitted sample and does not verify other batches.
Published records with a non-null purity or measured-versus-label amount result. Matching uses a normalized compound slug. No deduplication in this archive summary; relays and corrected records can remain separate. Records with neither measurement are excluded here, but can appear in the research overview's exact-token raw-record total. These are not unique certificates or batches. TitrateLab indexes reports from third-party laboratories.
Aggregate calculated: 2026-09-12T10:54:47.132687+00:00. Calculation time is not a test date.
Published records8
Reported purity99.6% median · 8 results
Dose accuracy100% within ±10% · 4 results
Endotoxin100% pass · 2 determinate results
Evidence dates2026-01-16 to 2026-09-08
Limits and missing evidence
Coverage depends on reports that were published and available to ingest.
Assay metrics
Liraglutide lab-testing metrics
8
Certificates
99.6%
Median reported purity (zero included)
100%
Purity records ≥ 99%
0
Source records reporting zero purity
1
Testing labs
5
Vendors
Mean purity99.6%Below 90% purity0%Mean dose vs label-0.4%Underfilled0%Endotoxin pass100%Within 10% of label dose100%Overdosed ≥ +7%0%Underdosed ≤ −7%25%
COAs per testing lab
Every lab testing Liraglutide in the corpus.
Freedom Diagnostics899.6% med
Tested-purity distribution
Bins below 90% tested purity (0% of numeric purity records).
Liraglutide tested-purity distribution
Purity range
Certificates
0–50%
0
50–70%
0
70–80%
0
80–85%
0
85–90%
0
90–91%
0
91–92%
0
92–93%
0
93–94%
0
94–95%
0
95–96%
0
96–97%
0
97–98%
0
98–99%
0
99–100%
8
COAs over time
Liraglutide source records by test month (discovery month when test date is absent).
Open a compound, then a COA to inspect its measurements. This preview includes source-linked, deduplicated reports with a usable result. Its coverage can differ from the broader report count above.
Connect these results to a vendor.
Pro reveals the name and gives you access to the lab-report archive.
This chart compares report counts for this compound. A larger test history does not establish better purity, dose accuracy or endotoxin results. Inspect the individual reports to compare measurements.
Connect these results to a vendor.
Pro reveals the name and gives you access to the lab-report archive.
This chart compares report counts for this compound. A larger test history does not establish better purity, dose accuracy or endotoxin results. Inspect the individual reports to compare measurements.
Connect these results to a vendor.
Pro reveals the name and gives you access to the lab-report archive.
This chart compares report counts for this compound. A larger test history does not establish better purity, dose accuracy or endotoxin results. Inspect the individual reports to compare measurements.
Connect these results to a vendor.
Pro reveals the name and gives you access to the lab-report archive.
This chart compares report counts for this compound. A larger test history does not establish better purity, dose accuracy or endotoxin results. Inspect the individual reports to compare measurements.
Connect these results to a vendor.
Pro reveals the name and gives you access to the lab-report archive.